Drug Database
Back to search

Poland· PL-100474211

Aludran

A cinnarizin, kombinationen product containing cinnarizinum + dimenhydrinatum, registered in Poland by Ranbaxy (Poland) Sp. z o.o.. The same ATC class is registered in 9 of our 19 countries.

ATC N07CA52

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAludranATCN07CA52REGISTER NO.PL-100474211PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cinnarizinum + dimenhydrinatumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cinnarizin, kombinationen is registered in 9 of 19 countries.

Countries holding a registration under ATC N07CA52 (cinnarizin, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search cinnarizin, kombinationen products by name

Cinnarizin, kombinationen · ATC N07CA52

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cinnarizin, kombinationen costs, country by country.

Normalised to the WHO defined daily dose (90 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Cinnarizin, kombinationen · price per daily dose (90 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.98
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Cinnarizinum + Dimenhydrinatum
Manufacturer
Ranbaxy (Poland) Sp. z o.o.
Country
Poland (PL)
ATC code
N07CA52
ATC class
Cinnarizin, Kombinationen
Defined daily dose
90 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991568948
  • gtin
    05909991568955
  • gtin
    05909991568962

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cinnarizin, kombinationen in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cinnarizin, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Arlevert
  • Belgium · Arlevertan
  • Bulgaria · Азалонум, Арлеверт
  • Cyprus · Arlevert, Azalonum
  • Czechia · Arlevert, Medovert
  • Germany · Arlevert, Cinna/Dimen
  • Denmark · Arlevert
  • Estonia · Arlevert, Azalonum
  • Spain · Dizinel
  • Finland · Arlevert
  • United Kingdom (Northern Ireland) · Arlevert, Cinnarizine/Dimenhydrinate Brown & Burk Uk
  • Greece · Arlevert, Azalonum
  • Croatia · Azalonum
  • Hungary · Arlevert
  • Ireland · Arlevert
  • Italy · Agivert, Arlevertan
  • Lithuania · Arlevert, Azalonum
  • Luxembourg · Arlevertan, Cinnarizin/Dimenhydrinat Micro Labs
  • Latvia · Arlevert, Azalonum
  • Malta · Azalonum
  • Netherlands · Arlevert
  • Portugal · Arlevert, Cinarizina + Dimenidrinato Biofarmoz
  • Romania · Arlevert, Azalonum
  • Sweden · Arlevert, Azalonum
  • Slovenia · Arlevert
  • Slovakia · Arlevert, Medovert

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a0708ece-0739-4119-b770-b2c5d68453e7
GET /v1/drugs/a0708ece-0739-4119-b770-b2c5d68453e7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "20 mg + 40 mg",
  "packaging": "05909991568948 ¦ Rp ¦ 161232\n20 tabl.\n05909991568955 ¦ Rp ¦ 161233\n60 tabl.\n05909991568962 ¦ Rp ¦ 161234\n100 tabl.",
  "substance": "Cinnarizinum 20 mg + Dimenhydrinatum 40 mg",
  "common_name": "Cinnarizinum + Dimenhydrinatum",
  "pl_product_id": "100474211",
  "pozwolenie_nr": "28953",
  "auth_procedure": "DCP",
  "authorisation_validity": "2030-04-01"
}
API referenceMCP serverPlans

See everything about cinnarizin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console